Manayon, Zyque S.
HRN: 21-91-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/14/2022
09/20/2022
IVT
4.5g
Q6
Immunocompromised State
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes